Literature DB >> 12505393

Recent developments in avian influenza research: epidemiology and immunoprophylaxis.

M Tollis1, L Di Trani.   

Abstract

Influenza A viruses have been isolated from humans, from several other mammalian species and a wide variety of avian species, among which, wild aquatic birds represent the natural hosts of influenza viruses. The majority of the possible combinations of the 15 haemagglutinin (HA) and nine neuraminidase (NA) subtypes recognized have been identified in isolates from domestic and wild birds. Infection of birds can cause a wide range of clinical signs, which may vary according to the host, the virus strain, the host's immune status, the presence of any secondary exacerbating microorganisms and environmental factors. Most infections are inapparent, especially in waterfowl and other wild birds. In contrast, infections caused by viruses of H5 and H7 subtypes can be responsible for devastating epidemics in poultry. Despite the warnings to the poultry industry about these viruses, in 1997 an avian H5N1 influenza virus was directly transmitted from birds to humans in Hong Kong and resulted in 18 confirmed infections, thus strengthening the pandemic threat posed by avian influenza (AI). Indeed, reassortant viruses, harbouring a combination of avian and human viral genomes, have been responsible for major pandemics of human influenza. These considerations warrant the need to continue and broaden efforts in the surveillance of AI. Control programmes have varied from no intervention, as in the case of the occurrence of low pathogenic (LP) AI (LPAI) viruses, to extreme, expensive total quarantine-slaughter programmes carried out to eradicate highly pathogenic (HP) AI (HPAI) viruses. The adoption of a vaccination policy, targeted either to control or to prevent infection in poultry, is generally banned or discouraged. Nevertheless, the need to boost eradication efforts in order to limit further spread of infection and avoid heavy economic losses, and advances in modern vaccine technologies, have prompted a re-evaluation of the potential use of vaccination in poultry as an additional tool in comprehensive disease control strategies. This review presents a synthesis of the most recent research on AI that has contributed to a better understanding of the ecology of the virus and to the development of safe and efficacious vaccines for poultry. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505393     DOI: 10.1053/tvjl.2002.0716

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  9 in total

1.  Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

Authors:  Haroldo Toro; De-chu C Tang; David L Suarez; Matt J Sylte; Jennifer Pfeiffer; Kent R Van Kampen
Journal:  Vaccine       Date:  2006-09-25       Impact factor: 3.641

2.  A proposed taxonomy for characterization and assessment of avian influenza outbreaks.

Authors:  Sule L Mohammed; Harold P Lehmann; George R Kim
Journal:  Int J Med Inform       Date:  2008-09-19       Impact factor: 4.046

3.  Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses.

Authors:  Yonghui Zhang; Xiaojing Lin; Guoqin Wang; Jianfang Zhou; Jian Lu; Honglan Zhao; Fengwei Zhang; Jia Wu; Chunqiong Xu; Ning Du; Zi Li; Ye Zhang; Xiaoyi Wang; Shengli Bi; Yuelong Shu; Hongning Zhou; Wenjie Tan; Xiaobing Wu; Zhihui Chen; Yue Wang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

4.  Avian influenza viral nucleocapsid and hemagglutinin proteins induce chicken CD8+ memory T lymphocytes.

Authors:  Shailbala Singh; Worthie E Briles; Blanca Lupiani; Ellen W Collisson
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

5.  High immune efficacy against different avian influenza H5N1 viruses due to oral administration of a Saccharomyces cerevisiae-based vaccine in chickens.

Authors:  Han Lei; Xin Lu; Shuangqin Li; Yi Ren
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

6.  Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.

Authors:  Isabelle Legastelois; Adolfo Garcia-Sastre; Peter Palese; Terrence M Tumpey; Taronna R Maines; Jacqueline M Katz; Frederick R Vogel; Catherine Moste
Journal:  Influenza Other Respir Viruses       Date:  2007-05       Impact factor: 4.380

Review 7.  Genetic changes that accompanied shifts of low pathogenic avian influenza viruses toward higher pathogenicity in poultry.

Authors:  El-Sayed M Abdelwhab; Jutta Veits; Thomas C Mettenleiter
Journal:  Virulence       Date:  2013-07-16       Impact factor: 5.882

8.  Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages.

Authors:  Jianfang Zhou; Helen K W Law; Chung Yan Cheung; Iris H Y Ng; J S Malik Peiris; Yu Lung Lau
Journal:  J Infect Dis       Date:  2006-02-27       Impact factor: 5.226

Review 9.  Global patterns of avian influenza A (H7): virus evolution and zoonotic threats.

Authors:  Mahmoud M Naguib; Josanne H Verhagen; Ahmed Mostafa; Michelle Wille; Ruiyun Li; Annika Graaf; Josef D Järhult; Patrik Ellström; Siamak Zohari; Åke Lundkvist; Björn Olsen
Journal:  FEMS Microbiol Rev       Date:  2019-11-01       Impact factor: 16.408

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.